What Researchers Did
Researchers investigated the combined use of Dimexid and hyperbaric oxygen (HBO) therapy for acute hematogenic osteomyelitis in 129 newborns and young infants.
What They Found
The combined therapy showed a positive therapeutic effect in all 129 patients, leading to improved general condition and normalization of blood indices. X-ray analysis further revealed reduced bone destruction and accelerated reparative processes in the bones.
What This Means for Canadian Patients
For Canadian patients, these findings suggest that Dimexid and HBO therapy may be beneficial components in the complex treatment of acute hematogenic osteomyelitis in infants. However, current pediatric guidelines and standard of care would need to be consulted for implementation.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A significant limitation of this study is the absence of a control group, which prevents a definitive comparison of the treatment's efficacy against standard care or placebo.